HUTCHMED (China) HCM
NASDAQ HCM
$12.63 +0.07 (+0.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

HUTCHMED (China) (HCM) Cash from Financing Activities (2018 - 2021)

HUTCHMED (China) (HCM) posted quarterly Cash from Financing Activities of $605.1 million for Q2 2021, up 4315.1% year-over-year from $13.7 million in Q2 2020, and up 2362.23% quarter-over-quarter from -$26.7 million in Q1 2021.

HUTCHMED (China) (HCM) Cash from Financing Activities (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has reported Cash from Financing Activities for 4 consecutive years, with $605.1 million the latest figure, recorded in Q2 2021.

  • In Q2 2021, Cash from Financing Activities rose 4315.1% year-over-year to $605.1 million; the TTM figure through Jun 2021 stood at $674.7 million (up 442.5% YoY), while the FY2025 annual figure was $7.8 million, up 125.55% from the prior year.
  • Cash from Financing Activities advanced to $605.1 million in Q2 2021 per HCM's latest filing, from -$26.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $605.1 million in Q2 2021 and bottomed at -$29.2 million in Q2 2019.
  • Historically, Cash from Financing Activities has averaged $56.8 million across 4 years, with a median of -$161000.0 in 2018.
  • Annual changes were most pronounced in 2019 — Cash from Financing Activities slumped 1017.16% — and 2020, when it jumped 32093.64%.
  • HUTCHMED (China)'s Cash from Financing Activities stood at $16.0 million in 2018, then jumped by 67.63% to $26.9 million in 2019, then tumbled by 153.36% to -$14.4 million in 2020, then jumped by 4315.1% to $605.1 million in 2021.
  • Business Quant data shows HCM's Cash from Financing Activities at $605.1 million in Q2 2021, -$26.7 million in Q1 2021, and -$14.4 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -1.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -813.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -1.13 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 122.40 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -1.24 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 63.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -74.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 HUTCHMED (China) 2.19 Bn 2.19 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 605.08 Mn
Jun 30, 2021 605.08 Mn
Mar 31, 2021 -26.75 Mn
Mar 31, 2021 -26.75 Mn
Jun 30, 2020 -14.36 Mn
Jun 30, 2020 -14.36 Mn
Mar 31, 2020 110.70 Mn
Mar 31, 2020 110.70 Mn
Dec 31, 2019 26.90 Mn
Dec 31, 2019 26.90 Mn
Sep 30, 2019 1.12 Mn
Sep 30, 2019 1.12 Mn
Jun 30, 2019 -29.17 Mn
Jun 30, 2019 -29.17 Mn
Mar 31, 2019 -346,000.00
Mar 31, 2019 -346,000.00
Dec 31, 2018 16.05 Mn
Dec 31, 2018 16.05 Mn
Sep 30, 2018 24,000.00
Sep 30, 2018 24,000.00